酮内酯类药物HMR 3647对近期革兰氏阳性临床分离株和流感嗜血杆菌的体外活性。
In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae.
作者信息
Barry A L, Fuchs P C, Brown S D
机构信息
The Clinical Microbiology Institute, Wilsonville, Oregon 97070, USA.
出版信息
Antimicrob Agents Chemother. 1998 Aug;42(8):2138-40. doi: 10.1128/AAC.42.8.2138.
Abstract
The ketolide HMR 3647 (previously RU 66647) was evaluated against 2, 563 recent clinical isolates of gram-positive pathogens and 200 Haemophilus influenzae isolates. HMR 3647 was active against macrolide-resistant streptococci, including pneumococci, but was not active against macrolide- or lincosamide-resistant staphylococci. Against H. influenzae, the potency of HMR 3647 was similar to that of azithromycin.
摘要
对酮内酯类药物HMR 3647（以前称为RU 66647）针对2563株近期临床分离的革兰氏阳性病原体和200株流感嗜血杆菌分离株进行了评估。HMR 3647对大环内酯类耐药链球菌，包括肺炎球菌有活性，但对大环内酯类或林可酰胺类耐药葡萄球菌无活性。对于流感嗜血杆菌，HMR 3647的效力与阿奇霉素相似。
相似文献
1
In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae.酮内酯类药物HMR 3647对近期革兰氏阳性临床分离株和流感嗜血杆菌的体外活性。
Antimicrob Agents Chemother. 1998 Aug;42(8):2138-40. doi: 10.1128/AAC.42.8.2138.
2
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.新型酮内酯类药物HMR 3004与氮杂内酯类和大环内酯类药物相比，对肺炎链球菌和流感嗜血杆菌的体外活性。
Eur J Clin Microbiol Infect Dis. 1997 Oct;16(10):767-9. doi: 10.1007/BF01709263.
3
In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004.新型酮内酯类抗菌剂RU-64004的体外评价
Antimicrob Agents Chemother. 1997 Feb;41(2):454-9. doi: 10.1128/AAC.41.2.454.
4
Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains.新型酮内酯类抗菌剂（HMR 3004和HMR 3647）对流感嗜血杆菌和卡他莫拉菌菌株的抗菌活性比较及杀菌曲线研究。
Diagn Microbiol Infect Dis. 1998 Jun;31(2):349-53. doi: 10.1016/s0732-8893(98)00022-4.
5
Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.新型酮内酯HMR 3647的合成及其对耐红霉素和敏感病原体的高效抗菌活性
Bioorg Med Chem Lett. 1999 Nov 1;9(21):3075-80. doi: 10.1016/s0960-894x(99)00534-x.
6
Antimicrobial activity of RU-66647, a new ketolide.新型酮内酯RU-66647的抗菌活性
Diagn Microbiol Infect Dis. 1997 Jan-Feb;27(1-2):7-12. doi: 10.1016/s0732-8893(96)00181-2.
7
In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.新型酮内酯类抗生素RU 64004对革兰氏阳性菌的体外活性
Antimicrob Agents Chemother. 1997 May;41(5):1196-202. doi: 10.1128/AAC.41.5.1196.
8
In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.新型酮内酯类抗生素HMR 3647对革兰氏阳性菌的体外活性
J Antimicrob Chemother. 1998 Sep;42(3):297-301. doi: 10.1093/jac/42.3.297.
9
In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci.HMR 3647对肺炎链球菌、流感嗜血杆菌、卡他莫拉菌和β溶血性链球菌的体外活性。
J Antimicrob Chemother. 1999 Oct;44(4):445-53. doi: 10.1093/jac/44.4.445.
10
In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.两种酮内酯类药物HMR 3647和HMR 3004对革兰氏阳性菌的体外活性
Antimicrob Agents Chemother. 1999 Apr;43(4):930-6. doi: 10.1128/AAC.43.4.930.
引用本文的文献
1
2
Antibiotics for treatment of resistant gram-positive coccal infections.用于治疗耐革兰氏阳性球菌感染的抗生素。
Indian J Pediatr. 2006 Apr;73(4):323-34. doi: 10.1007/BF02825827.
3
Recovery of interfering bacteria in the nasopharynx following antimicrobial therapy of acute maxillary sinusitis with telithromycin or amoxicillin-clavulanate.在使用泰利霉素或阿莫西林-克拉维酸对急性上颌窦炎进行抗菌治疗后，鼻咽部干扰细菌的恢复情况。
Antimicrob Agents Chemother. 2005 Nov;49(11):4793-4. doi: 10.1128/AAC.49.11.4793-4794.2005.
4
Telithromycin.泰利霉素
Drugs. 2004;64(15):1683-94; discussion 1695-6. doi: 10.2165/00003495-200464150-00006.
5
The ketolides: a critical review.酮内酯类药物：综述
Drugs. 2002;62(12):1771-804. doi: 10.2165/00003495-200262120-00006.
6
Intrapulmonary pharmacokinetics of telithromycin, a new ketolide, in healthy Japanese volunteers.新型酮内酯类药物泰利霉素在健康日本志愿者体内的肺内药代动力学。
Antimicrob Agents Chemother. 2002 Mar;46(3):917-21. doi: 10.1128/AAC.46.3.917-921.2002.
7
Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci.ABT-773与泰利霉素对大环内酯类敏感及耐药链球菌和葡萄球菌的体外活性比较。
Antimicrob Agents Chemother. 2002 Mar;46(3):783-6. doi: 10.1128/AAC.46.3.783-786.2002.
8
In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.泰利霉素（HMR3647）对肺炎链球菌和流感嗜血杆菌的体内疗效。
Antimicrob Agents Chemother. 2001 Nov;45(11):3250-2. doi: 10.1128/AAC.45.11.3250-3252.2001.
9
In vitro activity of the ketolide ABT-773.酮内酯ABT-773的体外活性
Antimicrob Agents Chemother. 2001 Oct;45(10):2922-4. doi: 10.1128/AAC.45.10.2922-2924.2001.
10
Telithromycin.泰利霉素
Drugs. 2001;61(6):815-29; discussion 830-1. doi: 10.2165/00003495-200161060-00016.
本文引用的文献
1
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).一种酮内酯（HMR 3647）、一种链阳菌素（奎奴普丁-达福普汀）、一种大环内酯（红霉素）和一种林可酰胺（克林霉素）的抗肺炎球菌活性。
Antimicrob Agents Chemother. 1998 Apr;42(4):945-6. doi: 10.1128/AAC.42.4.945.
2
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.新型酮内酯类药物HMR 3004与氮杂内酯类和大环内酯类药物相比，对肺炎链球菌和流感嗜血杆菌的体外活性。
Eur J Clin Microbiol Infect Dis. 1997 Oct;16(10):767-9. doi: 10.1007/BF01709263.
3
Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens.新型酮内酯衍生物RU 64004（HMR 3004）对呼吸道病原体的抗菌活性
Antimicrob Agents Chemother. 1997 Oct;41(10):2149-58. doi: 10.1128/AAC.41.10.2149.
4
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004).酮内酯类药物HMR 3647（RU 66647）和HMR 3004（RU 64004）的抗厌氧活性比较
Antimicrob Agents Chemother. 1997 Sep;41(9):2019-22. doi: 10.1128/AAC.41.9.2019.
5
Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA.美国门诊患者中肺炎链球菌和化脓性链球菌分离株的大环内酯类耐药情况。
J Antimicrob Chemother. 1997 Jul;40(1):139-40. doi: 10.1093/jac/40.1.139.
6
In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.新型酮内酯类抗生素RU 64004对革兰氏阳性菌的体外活性
Antimicrob Agents Chemother. 1997 May;41(5):1196-202. doi: 10.1128/AAC.41.5.1196.
7
Antimicrobial activity of RU-66647, a new ketolide.新型酮内酯RU-66647的抗菌活性
Diagn Microbiol Infect Dis. 1997 Jan-Feb;27(1-2):7-12. doi: 10.1016/s0732-8893(96)00181-2.
8
In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004.新型酮内酯类抗菌剂RU-64004的体外评价
Antimicrob Agents Chemother. 1997 Feb;41(2):454-9. doi: 10.1128/AAC.41.2.454.
Zotero 插件